HomeSGMT • NASDAQ
add
Sagimet Biosciences Inc
Previous close
$4.50
Day range
$4.35 - $4.77
Year range
$2.39 - $20.71
Market cap
153.25M USD
Avg Volume
792.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.90M | 78.82% |
Net income | -14.62M | -130.11% |
Net profit margin | — | — |
Earnings per share | -0.45 | -28.57% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.49M | 49.73% |
Total assets | 174.78M | 69.81% |
Total liabilities | 4.09M | -18.97% |
Total equity | 170.68M | — |
Shares outstanding | 30.67M | — |
Price to book | 0.85 | — |
Return on assets | -23.23% | — |
Return on capital | -23.86% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -14.62M | -130.11% |
Cash from operations | -19.57M | -404.49% |
Cash from investing | 624.00K | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -18.94M | -122.73% |
Free cash flow | -16.49M | -1,357.25% |
About
Founded
2006
Headquarters
Website
Employees
9
